← Leaderboards
Matthew Dean Shortridge
Ithax Pharmaceuticals, Inc.
$198,922
Attributed
$596,767
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $298.4K · FY2020–21$500K$375K$250K$125K$0
'20
'21
Funding mix
By agency
NIH$596,767 · 1
By mechanism
R41$596,767 · 1
Top collaborators
- Jonathan Karn2 shared
- Gabriele Varani2 shared
Others in their field
Other Emerging Leaders on “Advocate”
- Laura Ferrarese · Association Of Universities For Research In Astronomy, Inc.$47,742,424
- Olwen Hahn · Brigham And Women'S Hospital$10,950,424
- Ki Young Chung · Prisma Health - Upstate$9,859,012
- Judith O Hopkins · Southeast Clinical Oncol Res Consortium$8,283,998
- William J Irvin · Southeast Clinical Oncol Res Consortium$8,283,998
- Keith M Diaz · Columbia University Health Sciences$6,515,148
Research focus
AdvocateAffinityAnimalsAnti-Retroviral AgentsAntiretroviral TherapyAntiviral AgentsBaseBindingBiochemicalBiological ModelsBiotechnologyCapitalCd4 Positive T LymphocytesCell LineCell Membrane PermeabilityCell ModelCellsChemistryClinical InvestigationCommercializationComplexData CollectionDesignAcademia